1 ( concentrated electrolytes ) ก

Size: px
Start display at page:

Download "1 ( concentrated electrolytes ) ก"

Transcription

1 ก ก HAD 1 ( concentrated electrolytes ) ก ก ก ( ) ก ก ก ก 2 ก ก ก (Patient care unit) ก ก ก ก ( Hemodialysis ) ก ก ก ก ก ก stock card ก ก ( High Alert Drug (HAD)) ก ก ก ก (Pharmacy and Therapeutic Committee (PTC)) ก ( High Alert Drug (HAD)) ก ก / ก ก ก ก ก ก ก ( High Alert Drug(HAD) ก ก ก ก ก 17 ก 160 ก ก 1. ADRENERGIC AGONISTS, INJECTION Epinephrine (Adrenaline), Norepinephrine, Dopamine, Dobutamine 2. ADRENERGIC ANTAGONISTS,INJECTION Labetalol (Avexa ) 3. ANESTHETIC AGENTS Ketamine (Calypsol ), Propofol (Anepol, Fresofol ), ETOMIDATE, ISOFLURANE (Forane ), SEVOFLURANE (Sevorane ), THIOPENTONE (Pentothal ) 4. ANTIARRYTHMIC AGENTS LIDOCAINE (Charlocaine, Drocanil-A ), AMIODARONE (Cordarone ), ADENOSINE (Adenocor ), DILTIAZEM (Herbesser ) 5. ANTICOAGULANTS, THROMBOLYTIC/ FIBRINOLYTIC AGENTS HEPARIN (HEPARIN- LEO ), ENOXAPARIN SODIUM (CLEXANE ), NADROPARIN (FRAXIPARIN ), FONDAPARINUX (ARIXTRA ), WARFARIN ORAL (BEFARIN, ORFARIN ), ALTEPLASE (ACTILYSE ), STREPTOKINASE (STREPTASE ) 6. CYTOTOXIC AGENTS BEVACIZUMAB, BICALUTAMIDE, BLEOMYCIN, CARBOPLATIN, CETUXIMAB, CHLORAMBUCIL, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, DOCETAXEL, EPIRUBICIN, ETOPOSIDE, FLUOROURACIL, GEFITINIB, GEMCITABINE, HYDROXYUREA, IDARUBICIN, IFOSFAMIDE, IRINOTECAN, LETROZOLE, MEDROXYPROGESTERONE ACETATE, MEGESTROL ACETATE, MELPHALAN, MERCAPTOPURINE, METHOTREXATE oral, IV, Non- 1

2 oncologic use, MITOMYCIN, OXALIPLATIN, PACLITAXEL, TAMOXIFEN, VINBLASTIN, VINCRISTINE 7. CONCENTRATED ELECTROLYTES POTASSIUM CHLORIDE 20 meq/10ml, INJECTION, DIPOTASSIUM PHOSPHATE 20 meq/20 ml INJECTION, MAGNESIUM SULFATE 10%, INJECTION ( 1 gm ) SODIUM CHLORIDE 3% INJECTION, CALCIUM GLUCONATE 10% INJECTION, 7.5 % SODIUM BICARBONATE 50 ML, CARDIOPLEGIC SOLUTION 8. 50%GlUCOSE for INJECTION 50%GlUCOSE for INJECTION 20 ml, 50 ml 9. DIALYSIS SOLUTION DIALYSIS SOLUTION Peritoneal and hemodialysis 10. EPIDURAL OR INTRATHECAL MEDICATIONS LEVOBUPIVACAINE (CHIROCAINE ), BUPIVACAINE SPINAL/ EPIDURAL (MARCAINE ) 11. HYPOGLYCEMIC AGENTS AND INSULIN GLIBENCLAMIDE (BENCLAMIDE, DAONIL, GLUCOVANCE 2.5/500,5/500), GLIPIZIDE (DIPAZIDE, MINIDIAB ), GLICLAZIDE (DIAMICRON, DIAMICRON MR, DIANID, GLIZID-M ), GLIMEPIRIDE (AMARYL, AMARYL-M ), REPAGLINIDE (NOVONORM ), Insulin lispro (Humalog ), Regular Insulin (Humulin - R ), Insulin isophane suspension (Humulin- N ), Insulin glargine (Lantus ), Insulin detemir (Levemir ), Insulin aspart 30% (Novo Mix 30 HM ), Insulin lispro protamine suspension (Humalog Mix 25 ), Insulin 70/30 (Humulin70/30, Mixtard 30 HM ) 12. INOTROPIC MEDICATIONS Digoxin, Milrinone 13. MODERATE SEDATION AND NARCOTICS/ OPIATES MIDAZOLAM IV (DORMICUM ), DIAZEPAM (DIAPINE )10 mg IV, CHLORAL HYDRATE ORAL, MORPHINE SULFATE IV, Oral, FENTANYL IV, Transdermal (Durogesic ), PETHIDINE 14. NEUROMUSCULAR BLOCKING AGENTS SUCCINYL ( SICCUM ASTA ) 500 MG INJECTION, ATRACURIUM (TRACIUM ), PANCURONIUM (PAVULON ), ROCURONIUM (ESMERON ), CISATRACURIUM (NIMBEX ) 15. CONTRAST AGENT IOPROMIDE (ULTRAVIST ), IODIXANOL (VISIPLAQUE ), IOPAMIDOL (IOPAMIRO-300,370 ), IOXITHALAMATE (TELEBRIX ) 16. TOTAL PARENTERAL NUTRITION Oliclinomel N4-550E 2000 ml, N4-550E 1500 ml, N E 2000 ml, Kabiven Peripheral 1000 kcal (1440 ml),1400 kcal (1920 ml), Aminoleban 8% inj. 500 ml, 10% AMINOSOL SOLUTION 500 ML, Kidmin inj. 200 ml, 10%Lipovenos /10%Intralipid, 20%Lipovenos / 20 % Intralipid, NEO-AMIYU 200 ml, 6.5% VAMINOLACT 100 ML, 7% NEPHROSTERIL, ADDAMEL*N 10 ml 17. OTHER MEDICATION NITROGLYCERIN/ GLYCERYL TRINITRATE (NITROCINE ), SODIUM NITROPRUSSIDE, MISOPROSTAL ORAL (CYTOTEC ), OXYTOCIN 2

3 (SYNTOCINON ), Sterile water for injection, inhalation, and irrigation in containers of 100 ml or over ( Concentrated electrolytes ) Potassium chloride (KCL) กก ก 2 meq/ml, Potassium phosphate, Sodium chloride ( NaCl ) กก 0.9 % Magnesium sulfate ( MgSO4) ก 1 gm ( Concentrated electrolytes ) ก - Potassium chloride (KCL)(15%=20mEq/10ml ) injection - Dipotassium Phosphate ( K2HPO4 ) 20mEq/20ml injection - Sodium Chloride ( NaCl ) 3% injection 500 ml - Magnesium sulfate 10% ( 10 ml ) = 1 gram injection - Calcium gluconate 10 % injection - 7.5% Sodium bicarbonate - Hemodialysis ก Pheno A LC 1.75 W/Glu K=3 - Pheno A LC 2 W/Glu K=3 - Pheno A LC 2.5 W/Glu K=2 - Pheno A LC 2.5 W/Glu K=3 - Pheno A LC 3.5 W/Glu K=2 - Pheno B ก ก 1. ก 1.1 ก ก ก ก 1.2 ก ก ก ก ก 1.3 (ready-to-administer) (ready-to-use) ก 2. ก ก ก 2.1 ก ก ก ก ก ก ก 3

4 2.2 ก ก ก ก ก ก ก / ก ก ก, ก ก ก 2.3 Sticker ก ก ก 2.4 ก ก กก inchage ก กก 3. ก 3.1 ก 3.2 ก ก ก MoSO 4 ก MgSO ก ก / ก ก ก ก ก ก ก ก ก 4.1 location double check ก ก ก ก 2 ก ก Drug Related Problems (DRPs) 4.3 ก ก ก ก 4.4 ก ก ก ก ก ก ก ก ก 4.5 ก 1 ก ก 5. ก 5.1 double check ก ก ก 6 R ก ก ก ก ก ก กก ก double check ก ก ( High Alert Drug (HAD)) ก ก ก High Alert Drugs 5.4 ก ก ก กก ก ก ก 6. ก ก ก กก 4

5 6.1 ก กก ก ก nurse note 6.2 ก ก ก ก ก 6.3 ก 7. ก ก 7.1 ก ก High Alert Drug 7.2 ก High Alert Drug 7.3 ก High Alert Drug ก ก 5

UP Health System Marquette Medication Guideline High Alert Drugs

UP Health System Marquette Medication Guideline High Alert Drugs 1 ALTEPLASE SOLR 100 MG ACTIVASE 305010 50242008527 TRUE ALTEPLASE SOLR 50 MG ACTIVASE 305008 50242004413 TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV 305035 63323061609 TRUE AMIODARONE INJ 50 MG/ML CORDARONE

More information

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations Conflict of Interest Declaration High Risk Medications in the Hospital Pharmacy None to disclose Monika Gil, Pharm.D. Clinical Staff Pharmacist Rush University Medical Center Chicago, IL Learning Objectives

More information

Critical Care Standard Infusion Concentrations

Critical Care Standard Infusion Concentrations Acetylcisteine (NAC) Actrapid - Human Insulin Addiphos 20mmol Addiphos 40mmol Adrenaline (Epinephrine) vs peripheral 10 g in 50mL 200mg per ml 50 units in 50mL 1 unit per ml sodium chloride 20 mmol in

More information

Don't forget to see our PharmaTags: Sterile Medication Labels at

Don't forget to see our PharmaTags: Sterile Medication Labels at PharmaTags: Anaesthesia Roll Labels Order Form Toll Free: 1 888 299 2661 PRICING: 10 Rolls Same Medication Label=$5.75/Roll or $57.50 Box Mix and Match 10 Rolls= $6.25/Roll or $62.50/Box Minimum Order

More information

Checklist/Action Plan for the Management of High-Alert Medications

Checklist/Action Plan for the Management of High-Alert Medications ... Attachment 1.G Checklist/Action Plan for the Management of High-Alert Medications (adapted from High-Alert Medications: Safeguarding Against Errors by Michael Cohen and Charles Kilo, In: Medication

More information

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial

More information

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!! UICCEMLCostingScenarios BackoftheEnvelope Calculations PreparedforWorkingGroupSession:19621November2014,Geneva MethodsSummary We have chosen a conservative approach, calculating cost per vial. We have

More information

ANESTHESIA DRUG REVIEW

ANESTHESIA DRUG REVIEW ANESTHESIA REVIEW CAPA S 39 TH ANNUAL CONFERENCE PALM SPRINGS OCTOBER 10, 2015 ROBERT F. KOPEL, MD, FACP, FCCP HOAG HOSPITAL CARDIAC ANESTHESIOLOGIST ASSISTANT CLINICAL PROFESSOR UCLA SCHOOL OF MEDICINE

More information

NOTICES DEPARTMENT OF HEALTH

NOTICES DEPARTMENT OF HEALTH NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [42 Pa.B. 4229] [Saturday, July 7, 2012] Under 28 Pa. Code 1005.11(b) (relating to drug use, control and security), the following

More information

Adult Critical Care Intravenous Infusions Titration Protocol

Adult Critical Care Intravenous Infusions Titration Protocol Adult Critical Care Intravenous Infusions Protocol Nursing staff to titrate drip to achieve goal ordered by provider in assigned time intervals. Amiodarone (Pacerone ) Argatroban Non-heparin anticoagulant

More information

Exhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A

More information

Guidelines for the Use of Anti-Emetics with Chemotherapy

Guidelines for the Use of Anti-Emetics with Chemotherapy Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting

More information

MASCC Guidelines for Antiemetic control: An update

MASCC Guidelines for Antiemetic control: An update MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,

More information

HIGH ALERT MEDICATIONS

HIGH ALERT MEDICATIONS PAGE: 1 of 12 1. PURPOSE This policy describes minimum standards to assure that sites, departments, and areas in Aurora Health Care that handle high risk medications have considered the risk of error associated

More information

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document

More information

The following are J Code requirements

The following are J Code requirements The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based

More information

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation. 0542-02 Adenosine 6mg, 2ml Vial (limited qty on hand) 0301-67 Adenosine 6mg, 2ml LL Syringe 0651-04 ADENOSINE 12MG 4ML SDV 0301-68 Adenosine 12mg, 4ml LLSyringe early early 0302-66 Amiodarone 150mg, 3ml

More information

the generation of arcomed Where functionality meets safety!

the generation of arcomed Where functionality meets safety! the generation of arcomed Where functionality meets safety! «What do I want?» asks the mind desire Immanuel Kant «What s the point?» asks the faculty of judgement +function Immanuel Kant «What s the result?»

More information

Customer Service: Shop online at

Customer Service: Shop online at Effective May 1, 2017 Item Number Changes for Pharmaceuticals Due to changes in regulatory requirements, effective May 1, 2017, some of our pharmaceuticals' units of sale will change. The table below outlines

More information

IV Medication Drip Chart

IV Medication Drip Chart IV Medication Drip Chart Index Summary chart 2 IV Medication drip chart Amiodarone 2 Atracurium 2, 5 Cisatracurium 2, 5 Dexmedetomidine 2 Dobutamine 2, 6 Dopamine 2, 6 Epinephrine 2, 7 Esmolol 2, 7 Etomidate

More information

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH Page 1 of 8 ADMINISTRATION OF MEDICATION BY IV PUSH AUDIENCE POLICY This document is directed to Registered Nurses (RNs), Licensed Vocational Nurses (LVN s), and physicians. The following delineates the

More information

Emetogenicity level 1. Emetogenicity level 2

Emetogenicity level 1. Emetogenicity level 2 Emetogenicity level 1 15 mins Pre-Chemo Maxalon 10mg po During chemo and Post Chemo 3 days Maxalon10mg po 8 hourly Increase Maxalon 20mg po 8 hourly Change to Cyclizine 50mg po 8 hourly 3 days If nausea

More information

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA

More information

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black

More information

CHAPTER II DRUG INDUCED PULMONARY DISEASES. BY J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY

CHAPTER II DRUG INDUCED PULMONARY DISEASES. BY J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY CHAPTER II DRUG INDUCED PULMONARY DISEASES BY J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY Drug Induced Pulmonary Disorders Is almost always a diagnosis

More information

Blanchard Valley Hospital Pharmacy Code Blue Overview

Blanchard Valley Hospital Pharmacy Code Blue Overview Blanchard Valley Hospital Pharmacy Code Blue Overview Adapted from Gary Spanik, RPh Edited by Kate Reeves, Pharm D, RPh Jon Manocchio, Pharm D, RPh Pharmacist Responsibilities Be aware of basic ACLS tenets

More information

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,

More information

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For

More information

Our mission is better health care outcomes.

Our mission is better health care outcomes. Our mission is better health care outcomes. Purity Product Catalog December 2018 nephronpharm.com 1 (844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic respiratory and

More information

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies: VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Incidence: The incidence of acute and delayed N&V was investigated in highly and moderately emetogenic

More information

Chapter / Section / Drug

Chapter / Section / Drug 2 Cardiovascular System 2.1 Positive inotropic drugs Digoxin Digoxin specific antibody ( DigiFab ) 2.2 Diuretics 2.2.1 Thiazides and related diuretics Indapamide (1 st Line) Bendroflumethiazide Metolazone

More information

CHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A

CHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A CHAPTER 11 General and Local Anesthetics Eliza Rivera-Mitu, RN, MSN NDEG 26 A Anesthetics Agents that depress the central nervous system (CNS) Depression of consciousness Loss of responsiveness to sensory

More information

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No. LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml

More information

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe) Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension

More information

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,

More information

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,

More information

DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days

DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days Last updated Oct 17, 2018 Tumour Group Protocol Number Protocol Name on NCCP website Breast 200 Trastuzumab (IV) Monotherapy 21 days 201 Trastuzumab (IV) Monotherapy 7 days 202 DOCEtaxel Monotherapy 100mg/m2

More information

Release of the 2017/18 Invitation to Tender

Release of the 2017/18 Invitation to Tender 2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s

More information

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole

More information

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Last updated Feb 9, 2018 Revision due Protocol Name on NCCP website Tumour Group Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Two Day Etoposide CISplatin

More information

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy Last Updated 22-Feb-18 Date of last update Protocol Number Tumour Group Protocol Name on NCCP website 22/02/2018 221 Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy 249 Gynaecology Intrathecal

More information

Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes

Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Where positive identification meets safe, efficient patient care. Improve Patient Safety with Accurate Medication Labeling

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

North Carolina College of Emergency Physicians Standards for EMS Medications and Skills Use

North Carolina College of Emergency Physicians Standards for EMS Medications and Skills Use . The baseline medications and skills required in all systems and Specialty Care Transport Programs) with EMS personnel credentialed at the specified level. S. The equipment required in all Specialty Care

More information

Look-Alike/Sound-Alike (LASA) Medication Chart

Look-Alike/Sound-Alike (LASA) Medication Chart Look-Alike/Sound-Alike (LASA) Medication Chart Last Revised: August 2018 Lipid based amphotericin products amphotericin B lipid complex (Abelcet ) amphotericin B liposomal (Ambisome ) Conventional forms

More information

Our mission is better health care outcomes.

Our mission is better health care outcomes. Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog March 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic

More information

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364 G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288

More information

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

Davis s Drug Guide Scavenger Hunt 15 th Edition

Davis s Drug Guide Scavenger Hunt 15 th Edition Davis s Drug Guide Scavenger Hunt 15 th Edition This handout is designed to assist you in locating information in the Davis s Drug Guide. Take advantage of the many resources in this text!! Locate the

More information

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation. September 28, 2018 Pharmaceutical Backorder Report BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description 0542-02 Adenosine 6mg, 2ml Vial (limited

More information

Our mission is better health care outcomes.

Our mission is better health care outcomes. Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog April 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic

More information

Adult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference

Adult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference CA2 Nationally standardised Dose banding for Adult Intravenous Anticancer Therapy (SACT) Scheme Name CA2: Nationally Standardised Dose Banding for Adult Intravenous Systemic Anticancer Therapy (SACT) Section

More information

FOR A HIGHER DEGREE OF CONFIDENCE

FOR A HIGHER DEGREE OF CONFIDENCE SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS. > Introduction Manufacturing specialized products in a pharmaceutical manufacturing environment has a specific set of requirements

More information

Patient 1: Patient 2:

Patient 1: Patient 2: Appendix A Compiled by Dr. Raymond Ngeh and Dr. Robert Luk Clinical notes and PET/CT scan images of eleven patients: 1. Middle age woman has cancer of the pancreas in the body of the gland. After just

More information

Medication Safety and High Alert Medications

Medication Safety and High Alert Medications Medication Safety and High Alert Medications Objectives At the completion of this presentation participants should: 1. Be able to identify what a high alert medication is and what medications are considered

More information

Guideline Update on Antiemetics

Guideline Update on Antiemetics Guideline Update on Antiemetics Clinical Practice Guideline Special Announcements Please check www.asco.org/guidelines/antiemetics for current FDA alert(s) and safety announcement(s) on antiemetics 2 Introduction

More information

SCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders

SCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders 1.0 Introduction The (SCI) is a not-for-profit collaboration between the Hospital for Sick Children (SickKids), Toronto, Canada, and seven Caribbean health care institutions across six countries that strive

More information

Pharmacology in Critical Care: What are We Giving?

Pharmacology in Critical Care: What are We Giving? 1 Pharmacology in Critical Care: What are We Giving? J. Brady Scott, MS, RRT ACCS Assistant Professor Respiratory Care Rush University Medical Center 1 Conflict of Interest I disclose affiliations with

More information

1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation.

1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation. Alberta Regulation 18/2005 Cancer Programs Act AMENDMENT REGULATION Filed: February 22, 2005 For information only: Made by the Minister of Health and Wellness (M.O. 9/2005) on February 17, 2005 pursuant

More information

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site Supplementary Table 1. ICD-9-CM codes used to define cancer ICD-9 Diagnosis code 140.xx-172.xx 174.xx-195.xx 196.xx 198.xx 199.xx 200.xx-208.xx Description Primary malignant neoplasms, not lymphatic or

More information

Vasco OP Underglove Sterile Surgical and Protective Gloves

Vasco OP Underglove Sterile Surgical and Protective Gloves data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Underglove gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical

More information

1 ml) (100 x. 10 ml)

1 ml) (100 x. 10 ml) SCHEDULE COPY NICIPAL CORPORATION OF GREATER MUM NTRAL PURCHASE AUTHORITY DEPARTME SCHEDULE I OF 2010-2011 INJECTIONS & SERA VACCINES CONTRACT PERIOD : 1-1-2010 To 31-12-2011 Item Description Quantity

More information

Section 8.4 Special Dilutions

Section 8.4 Special Dilutions Section 8.4 Special Dilutions Terminology: Diluent: Pediatric Compound Sterile Preparations (CSPs): Special Dilutions: Calculating Special Dilutions: Ratio-Proportion vs Dimensional Analysis Part A Calculating

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS

More information

ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY DISCLAIMER

ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY DISCLAIMER European Medicines Agency Evaluation of Medicines for Human Use ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY London, October 2006 Doc. Ref: EMEA/405166/2006 DISCLAIMER The Paediatric Working Party

More information

MEDICAL NECESSITY GUIDELINE

MEDICAL NECESSITY GUIDELINE PAGE: 1 of 10 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted

More information

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019 5-Fluorouracil 5-FU, Fluorouracil Stability Indicating HPLC-UV USP 7-keto DHEA Stability Indicating HPLC-UV Medisca Tier 1 Acetaminophen Stability Indicating HPLC-UV USP Adenosine Alprostadil PGE-1, Prostaglandin

More information

APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer

APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer 5850/5980 University Avenue, PO Box 9700, Halifax, N.S. B3K 6R8 PEDIATRIC HEMATOLOGY/ONCOLOGY

More information

Chapter 2 ~ Cardiovascular system

Chapter 2 ~ Cardiovascular system Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection

More information

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion

More information

Clinical Manual. Part 4 Standard Drug List. Version 8.1 July [Type text]

Clinical Manual. Part 4 Standard Drug List. Version 8.1 July [Type text] Clinical Manual Part 4 Standard Drug List Version 8.1 July 2018 [Type text] Royal Flying Doctor Service Western Operations 3 Eagle Drive, Jandakot Airport, Western Australia 6164 T 61-8-9417 6300 F 61-8-9417

More information

SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS

SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS Manufacturing specialized products in a pharmaceutical

More information

North Carolina Medical Board Approved Medications for Credentialed EMS Personnel

North Carolina Medical Board Approved Medications for Credentialed EMS Personnel North Carolina Medical Board Approved Medications for Credentialed EMS Personnel EMS personnel at any level who administer medications must do so within an EMS system that provides medical oversight. Personnel

More information

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and 35 Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and Biologically directed therapies ) 1 1- Nausea and vomiting

More information

An introduction to the Essential Medicines concept: balancing innovation with public health priorities

An introduction to the Essential Medicines concept: balancing innovation with public health priorities An introduction to the Essential Medicines concept: balancing innovation with public health priorities WHO HQ, Geneva 11 October 2017 Nicola Magrini Secretary, WHO Expert Committee on the Selection and

More information

DRUG EXTRAVASATION. Vesicants. Irritants

DRUG EXTRAVASATION. Vesicants. Irritants DRUG EXTRAVASATION Vesicants Irritants Vesicants Antineoplastic drugs Amsacrine Dactinomycin Daunorubicin Docetaxel (rare) Doxorubicin Epirubicin Idarubicin Mechlorethamine Mitomycin Oxaliplatin (rare)

More information

Medical Therapies in Ovarian Cancer The Arabic Perspectives. Mezghani Bassem -Tunisia

Medical Therapies in Ovarian Cancer The Arabic Perspectives. Mezghani Bassem -Tunisia Tunisian Health System: Social Welfare with a Public insurance for all citizens including Indigent persons. (± Additional private insurance) Choice: Public Hospital/Private Clinics (Indigents Public H)

More information

Original Date of issue: 01/11/2005 Last Reviewed: 01/05/2011 Version:4 Page 1 of 7

Original Date of issue: 01/11/2005 Last Reviewed: 01/05/2011 Version:4 Page 1 of 7 Original Date of issue: 01/11/2005 Last eviewed: 01/05/2011 Version:4 Page 1 of 7 15: Anaesthesia 15.1 General anaesthesia 15.1.1 Intravenous anaesthesia Etomidate Injection (20mg/10ml) Ketamine Injection

More information

North Carolina Medical Board Approved Medications for Credentialed EMS Personnel

North Carolina Medical Board Approved Medications for Credentialed EMS Personnel North Carolina Medical Board Approved Medications for Credentialed EMS Personnel EMS personnel at any level who administer medications must do so within an EMS system that provides medical oversight. Personnel

More information

Vasco OP Free Sterile Surgical and Protective Gloves

Vasco OP Free Sterile Surgical and Protective Gloves DATA SheeT EN 374:2003 EN 374:2003 AQl 0.65 B. Braun Melsungen AG confirms that Vasco OP Free gloves comply with the following standards and directives: ec certificates AnD APPlieD STAnDArDS Medical device

More information

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES CURRENT DRUG SHORTAGES (through February 22, 2013) CRITICAL SHORTAGES Acetylcysteine Inhalation Analgesic Buprenorphine Caffeine and Ergotamine Acyclovir Meperidine Injection Adenosine Amino Acid Products

More information

Vasco OP Sensitive Sterile Surgical and Protective Gloves

Vasco OP Sensitive Sterile Surgical and Protective Gloves data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Sensitive gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical

More information

Active Pharmaceutical Ingredient (API) List List Updated 03/08/2018

Active Pharmaceutical Ingredient (API) List List Updated 03/08/2018 5-Fluorouracil HPLC/ UHPLC Yes USP 4017 30 5mL 2 7-keto DHEA HPLC/ UHPLC Yes Medisca 4258 180 5mL 1 Acetaminophen HPLC/ UHPLC Yes USP 4406 5mL 2 Acetylcysteine HPLC/ UHPLC Yes USP 4255 60 5mL 1 Adenosine

More information

VMG Pharmaceuticals Pvt. Ltd.

VMG Pharmaceuticals Pvt. Ltd. S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets

More information

CANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs

CANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs CANCER PREVENTION AND ACCESS TO MEDICINES Gracemarie Bricalli ESMO Head of International Affairs ESMO s 2020 Vision: Access to cancer care ESMO s 2020 vision statement recognises that progress in the management

More information

UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE

UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Subject: Hazardous Drugs and Chemicals IAC.657-7.8(10) (Formerly High Alert and Hazardous Medications MM.01.01.03) (Formerly

More information

Insulin Prior Authorization with optional Quantity Limit Program Summary

Insulin Prior Authorization with optional Quantity Limit Program Summary Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)

More information

COVERSYL 5 3,730 PERINDOPRIL COVERSYL PERINDOPRIL COVERSYL PLUS 4,125 PERINDOPRIL+INDAPAMIDE غير متوفر CLEXANE ,010 ENOXAPARIN

COVERSYL 5 3,730 PERINDOPRIL COVERSYL PERINDOPRIL COVERSYL PLUS 4,125 PERINDOPRIL+INDAPAMIDE غير متوفر CLEXANE ,010 ENOXAPARIN مالحظات التركيب العلمي السعر الدواء األجنبي SERETIDE-500 7,425 FLUTICASONE+ SALMETEROL SERETIDE-100 4,265 FLUTICASONE+ SALMETEROL ATROVENT INHALER 1,970 IPRATROPIUM IMURAN 2,500 AZATHIOPRINE VENTOLIN DISKUS

More information

Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC

Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC Medication Review Cancer Chemotherapy Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Cancer Chemotherapy Drugs PassAssured's Pharmacy Technician Training Program Medication

More information

1. Purpose Documentation Description.1 4. References 8 5. Cross-References.8 6. Development of the guideline.8

1. Purpose Documentation Description.1 4. References 8 5. Cross-References.8 6. Development of the guideline.8 CLINICAL GUIDELINE For use in (clinical areas): For use by (staff groups): For use for (patients): Document owner: Status: Oncology/Haematology Unit (excluding Paediatrics) Oncologists, Haematologists,

More information

Antiemetics: Guidelines, Interactions and more.

Antiemetics: Guidelines, Interactions and more. Antiemetics: Guidelines, Interactions and more. Chemotherapy-induced side effects -the patient s view Loss of hair The thought of coming for chemo Affects family/partner Affects work/home duties Jude Lees

More information

Module 8: Practice Problems

Module 8: Practice Problems Module 8: Practice Problems 1. Convert a blood plasma level range of 5 to 20 µg/ml of tobramycin (Z = 467.52) to µmol/l. 5 µg/ml = 10.7 µmol/l 20 µg/ml = 42.8 µmol/l 2. A preparation contains in each milliliter,

More information

Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients

Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients POGO Antineoplastic Induced Nausea and Vomiting Guideline Development Panel: L.

More information

Procedure. AREAS OF RESPONSIBILITY All UNMH staff.

Procedure. AREAS OF RESPONSIBILITY All UNMH staff. Page 1 of 8 Title: High Alert, and Look-Alike Sound-Alike Medications Applies To: UNM Hospitals Responsible Department: Pharmacy Procedure Patient Age Group: ( ) N/A (X) All Ages ( )Newborns ( )Pediatric

More information

Miracalus Pharma Pvt Limited

Miracalus Pharma Pvt Limited Dealers in Vaccines, TPN, Blood products and All Anti-Cancer Drugs Miracalus Pharma Pvt Limited ANTI CANCER - Injections ING CISPLATIN 10MG CISTEEN 1 VIAL ING CISPLATIN 50MG CISTEEN 1 VIAL INJ 5 FLURO

More information

WHO Model List (revised April 2002)

WHO Model List (revised April 2002) Essential Medicines Explanatory Notes The complementary list presents essential medicines for priority diseases which are efficacious, safe and cost-effective but not necessarily affordable, or for which

More information

Zzbeacon,Zayna [MR ]

Zzbeacon,Zayna [MR ] AALL1131 INTERIM MAINTENANCE, HR-ALL, ARM B, HD MTX Properties Cycle 1 9/27/2012 through 11/28/2012 (63 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release CBC and differential Release Release

More information